(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes (Q45212807)
Jump to navigation
Jump to search
scientific article published in January 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes |
scientific article published in January 2005 |
Statements
1 reference
(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes (English)
1 reference
Dooseop Kim
1 reference
Liping Wang
1 reference
Maria Beconi
1 reference
George J Eiermann
1 reference
Michael H Fisher
1 reference
Huaibing He
1 reference
Gerard J Hickey
1 reference
Jennifer E Kowalchick
1 reference
Barbara Leiting
1 reference
Kathryn Lyons
1 reference
Frank Marsilio
1 reference
Margaret E McCann
1 reference
Reshma A Patel
1 reference
Aleksandr Petrov
1 reference
Giovanna Scapin
1 reference
Sangita B Patel
1 reference
Ranabir Sinha Roy
1 reference
Joseph K Wu
1 reference
Matthew J Wyvratt
1 reference
Bei B Zhang
1 reference
Lan Zhu
1 reference
Nancy A Thornberry
1 reference
Ann E Weber
1 reference
1 January 2005
1 reference
1 reference
Identifiers
1 reference